Drug Trial Radar · NCT05809830
Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas
Last checked: Nov 19, 2026Latest source record: Mar 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
152
Planned (sponsor's estimate)
Start
May 29, 2023
Primary completion
Jun 20, 2025
Study completion May 8, 2026
Sponsor
- Lead sponsor
- Grupo Espanol de Investigacion en SarcomasAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 12, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase I dose-finding stage for the LB-100 plus doxorubicin combination is planned for an initial set of 9-18 patients (21-day cycles). After that, in the Phase II part, patients will be randomized (ratio 1:1) to either the experimental arm (LB-100 plus doxorubicin combination) or the control arm (doxorubicin alone) to, comparatively, evaluate the efficacy of the LB-100 plus doxorubicin combination vs. doxorubicin alone
Conditions
- Advanced Soft-tissue Sarcoma
Interventions
LB-100 plus DoxorrubicinDrug
In Phase one the intervention will be LB-100 plus Doxorrubicin. The experimental arm in Phase II will also be LB-100 plus Doxorrubicin
DoxorubicinDrug
The control arm in Phase II will be Doxorrubicin alone
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximun Tolerated Dose (MTD) (Phase I)Time frame: After six months
- Progression-free survival (PFS) (Phase II)Time frame: After two years
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Hospital de la Santa Creu i Sant Pau
Barcelona, Catalonia, Spain
Hospital Clínico San Carlos
Madrid, Madrid, Spain
Hospital Fundación Jiménez Díaz
Madrid, Madrid, Spain
Hospital Universitario La Paz
Madrid, Madrid, Spain
Hospital Clínico Universitario Virgen de la Arrixaca
Murcia, Murcia, Spain
Hospital Clínico Universitario de Valencia
Valencia, Valencia, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.